Elyse Lower, MD

Hunt, Brian G; Wicker, Christina A; Bourn, Jennifer R; Lower, Elyse E; Takiar, Vinita; Waltz, Susan E 2020. MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients. Breast cancer research and treatment, 181 3, 529-540

Kittaneh, Muaiad; Badve, Sunil; Caldera, Humberto; Coleman, Robert; Goetz, Matthew P; Mahtani, Reshma; Mamounas, Eleftherios; Kalinsky, Kevin; Lower, Elyse; Pegram, Mark; Press, Michael F; Rugo, Hope S; Schwartzberg, Lee; Traina, Tiffany; Vogel, Charles 2020. Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG). Clinical breast cancer, ,

Rahaghi, Franck F; Baughman, Robert P; Saketkoo, Lesley Ann; Sweiss, Nadera J; Barney, Joseph B; Birring, Surinder S; Costabel, Ulrich; Crouser, Elliott D; Drent, Marjolein; Gerke, Alicia K; Grutters, Jan C; Hamzeh, Nabeel Y; Huizar, Isham; Ennis James, W; Kalra, Sanjay; Kullberg, Susanna; Li, Huiping; Lower, Elyse E; Maier, Lisa A; Mirsaeidi, Mehdi; Müller-Quernheim, Joachim; Carmona Porquera, Eva M; Samavati, Lobelia; Valeyre, Dominique; Scholand, Mary Beth 2020. Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. European respiratory review : an official journal of the European Respiratory Society, 29 155,

Rahaghi, Franck F; Sweiss, Nadera J; Saketkoo, Lesley Ann; Scholand, Mary Beth; Barney, Joseph B; Gerke, Alicia K; Lower, Elyse E; Mirsaeidi, Mehdi; O'Hare, Lanier; Rumbak, Mark J; Samavati, Lobelia; Baughman, Robert P 2020. Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study. European respiratory review : an official journal of the European Respiratory Society, 29 155,

Shlobin, Oksana A; Kouranos, Vasilis; Barnett, Scott D; Alhamad, Esam H; Culver, Daniel A; Barney, Joseph; Cordova, Francis C; Carmona, Eva M; Scholand, Mary Beth; Wijsenbeek, Marlies; Ganesh, Sivagini; Lower, Elyse E; Engel, Peter J; Wort, John; Price, Laura; Wells, Athol U; Nathan, Steven D; Baughman, Robert P 2020. Physiological Predictors of Survival in Patients with Sarcoidosis Associated Pulmonary Hypertension: Results from an International Registry. The European respiratory journal, ,

Sweiss, Nadera J; Korsten, Peter; Syed, Huzaefah; Syed, Aamer; Baughman, Robert P; Yee, Arthur M F; Culver, Daniel A; Sosenko, Teresa; Azuma, Arata; Bonella, Francesco; Costabel, Ulrich; Drake, Wonder P; Drent, Marjolein; Lower, Elyse E; Israel-Biet, Dominique; Mostard, Remy L M; Nunes, Hilario; Rottoli, Paola; Spagnolo, Paolo; Wells, Athol U; Wuyts, Wim A; Judson, Marc A 2020. When the Game Changes: Guidance to Adjust Sarcoidosis Management During the COVID-19 Pandemic. Chest, ,

Lower, Elyse E; Sturdivant, Madison; Grate, Lisa; Baughman, Robert P 2019. Use of third-line therapies in advanced sarcoidosis. Clinical and experimental rheumatology, ,

Mahtani, Reshma; Holmes, Frankie-Ann; Badve, Sunil; Caldera, Humberto; Coleman, Robert; Mamounas, Eleftherios; Kalinsky, Kevin; Kittaneh, Muaiad; Lower, Elyse; Pegram, Mark; Press, Michael F; Rugo, Hope S; Schwartzberg, Lee; Vogel, Charles 2019. A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer. Clinical breast cancer, ,

Abraham, Jame; Caldera, Humberto; Coleman, Robert; Elias, Anthony; Goetz, Matthew P; Kittaneh, Muaiad; Lower, Elyse; Mahtani, Reshma; Terry Mamounas, E; Pegram, Mark; Rugo, Hope; Schwartzberg, Lee; Traina, Tiffany; Vogel, Chuck 2018. Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG). Breast cancer research and treatment, 169 1, 1-7

Abraham, Jame; Coleman, Robert; Elias, Anthony; Holmes, Frankie Ann; Kalinsky, Kevin; Kittaneh, Muaiad; Lower, Elyse; Mahtani, Reshma; Terry Mamounas, E; Pegram, Mark; Vogel, Charles 2018. Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG). Breast cancer research and treatment, 171 1, 11-20

Baughman, Robert P; Lower, Elyse E 2018. Steroids for sarcoidosis: How much and for how long? Respiratory medicine, 138S , S5-S6

Baughman, Robert P; Lower, Elyse E; Kirkil, Gamze 2018. Response. Chest, 153 6, 1507-1508

Baughman, Robert P; Shlobin, Oksana A; Wells, Athol U; Alhamad, Esam H; Culver, Daniel A; Barney, Joseph; Cordova, Francis C; Carmona, Eva M; Scholand, Mary Beth; Wijsenbeek, Marlies; Ganesh, Sivagini; Birring, Surinder S; Kouranos, Vasilis; O'Hare, Lanier; Baran, Joanne M; Cal, Joseph G; Lower, Elyse E; Engel, Peter J; Nathan, Steven D 2018. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. Respiratory medicine, 139 , 72-78

Bickett, Alexandra N; Lower, Elyse E; Baughman, Robert P 2018. Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis. Chest, 154 5, 1052-1060

Kirkil, Gamze; Lower, Elyse E; Baughman, Robert P 2018. Predictors of Mortality in Pulmonary Sarcoidosis. Chest, 153 1, 105-113

Lower, Elyse E; Charif, Mahmoud; Bartelt, Meg 2018. Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study. Cancer chemotherapy and pharmacology, 82 1, 165-170

Walaszek, Kinga; Lower, Elyse E; Ziolkowski, Piotr; Weber, Georg F 2018. Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis. British journal of cancer, 119 10, 1259-1266

Yang, Yongguang; Leonard, Marissa; Zhang, Yijuan; Zhao, Dan; Mahmoud, Charif; Khan, Shugufta; Wang, Jiang; Lower, Elyse E; Zhang, Xiaoting 2018. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1. Cancer research, 78 2, 422-435

Baughman, Robert P; Sweiss, Nadera; Keijsers, Ruth; Birring, Surinder S; Shipley, Ralph; Saketkoo, Lesley Ann; Lower, Elyse E 2017. Repository corticotropin for Chronic Pulmonary Sarcoidosis. Lung, 195 3, 313-322

Freeman, C M; Xia, B T; Wilson, G C; Lewis, J D; Khan, S; Lee, S J; Lower, E E; Edwards, M J; Shaughnessy, E A 2017. Idiopathic granulomatous mastitis: A diagnostic and therapeutic challenge. American journal of surgery, 214 4, 701-706

Lower, Elyse E; Khan, Shagufta; Kennedy, Diane; Baughman, Robert P 2017. Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site. Breast cancer (Dove Medical Press), 9 , 515-520

Ruiz-Torres, Sasha J; Benight, Nancy M; Karns, Rebekah A; Lower, Elyse E; Guan, Jun-Lin; Waltz, Susan E 2017. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical ?-catenin signaling. Oncotarget, 8 35, 58918-58933

Zhou, Ying; Lower, Elyse E; Li, Hui-Ping; Costea, Alexandru; Attari, Mehran; Baughman, Robert P 2017. Cardiac Sarcoidosis: The Impact of Age and Implanted Devices on Survival. Chest, 151 1, 139-148

Zhou, Ying; Lower, Elyse E; Li, Huiping; Farhey, Yolanda; Baughman, Robert P 2017. Clinical characteristics of patients with bone sarcoidosis. Seminars in arthritis and rheumatism, 47 1, 143-148

Baughman, Robert P; Barney, Joseph B; O'Hare, Lanier; Lower, Elyse E 2016. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients. Respiratory medicine, 110 , 66-72

Baughman, Robert P; Judson, Marc A; Lower, Elyse E; Drent, Marjolein; Costabel, Ulrich; Flavin, Susan; Lo, Kim Hung; Barnathan, Elliot S 2016. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 32 4, 289-95

Zhou, Ying; Lower, Elyse E; Li, Huiping; Baughman, Robert P 2016. Clinical management of pulmonary sarcoidosis. Expert review of respiratory medicine, 10 5, 577-91

Zhou, Ying; Lower, Elyse E; Li, Huiping; Baughman, Robert P 2016. Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel. Respiratory medicine case reports, 17 , 5-7

Baughman, Robert P; Culver, Daniel A; Jankovi, Vladimir; Fischkoff, Steven; Brockway, Giorgia; Lower, Elyse E 2015. Placenta-derived mesenchymal-like cells (PDA-001) as therapy for chronic pulmonary sarcoidosis: a phase 1 study. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 32 2, 106-14

Baughman, Robert P; Lower, Elyse E 2015. Treatment of Sarcoidosis. Clinical reviews in allergy & immunology, 49 1, 79-92

Baughman, Robert P; Lower, Elyse E 2015. Features of sarcoidosis associated with chronic disease. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 31 4, 275-81

Baughman, Robert P; Lower, Elyse E; Saketkoo, Lesley Ann 2015. Clinical trials in pulmonary sarcoidosis. Current opinion in pulmonary medicine, 21 5, 525-31

Baughman, Robert P; Culver, Daniel A; Cordova, Francis C; Padilla, Maria; Gibson, Kevin F; Lower, Elyse E; Engel, Peter J 2014. Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial. Chest, 145 4, 810-817

Baughman, Robert P; Lower, Elyse E 2014. Medical therapy of sarcoidosis. Seminars in respiratory and critical care medicine, 35 3, 391-406

Carbone, Roberto G; Penna, Daniele; Baughman, Robert P; Lower, Elyse E 2014. Accuracy of Serial PET-CT Imaging in Systemic Sarcoidosis. Journal of clinical imaging science, 4 , 21

Baughman, R P; Janovcik, J; Ray, M; Sweiss, N; Lower, E E 2013. ??Calcium and vitamin D metabolism in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 30 2, 113-20

Baughman, Robert P; Lower, Elyse E 2013. Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients. Respiratory medicine, 107 12, 2009-13

Baughman, Robert P; Nunes, Hilario; Sweiss, Nadera J; Lower, Elyse E 2013. Established and experimental medical therapy of pulmonary sarcoidosis. The European respiratory journal, 41 6, 1424-38

Lower, Elyse E; Malhotra, Atul; Sudurlescu, Victoria; Baughman, Robert P 2013. Sarcoidosis, fatigue, and sleep apnea. Chest, 144 6, 1976-1977

Lower, Elyse E; Malhotra, Atul; Surdulescu, Victoria; Baughman, Robert P 2013. Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. Journal of pain and symptom management, 45 2, 159-69

Baughman, R P; Drent, M; Culver, D A; Grutters, J C; Handa, T; Humbert, M; Judson, M A; Lower, E E; Mana, J; Pereira, C A; Prasse, A; Sulica, R; Valyere, D; Vucinic, V; Wells, A U 2012. Endpoints for clinical trials of sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 29 2, 90-8

Baughman, R P; Lower, E E; Ingledue, R; Kaufman, A H 2012. Management of ocular sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 29 1, 26-33

Baughman, Robert P; Lower, Elyse E; Gibson, Kevin 2012. Pulmonary manifestations of sarcoidosis. Presse medicale (Paris, France : 1983), 41 6 Pt 2, e289-302

Lower, Elyse E; Baughman, Robert P; Kaufman, Adam H 2012. Rituximab for refractory granulomatous eye disease. Clinical ophthalmology (Auckland, N.Z.), 6 , 1613-8

Baughman, R P; Nagai, S; Balter, M; Costabel, U; Drent, M; du Bois, R; Grutters, J C; Judson, M A; Lambiri, I; Lower, E E; Muller-Quernheim, J; Prasse, A; Rizzato, G; Rottoli, P; Spagnolo, P; Teirstein, A 2011. Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 28 1, 56-64

Baughman, Robert P; Engel, Peter J; Taylor, Lisa; Lower, Elyse E 2010. Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest, 138 5, 1078-85

Baughman, Robert P; Lower, Elyse E; Kaufman, Adam H 2010. Ocular sarcoidosis. Seminars in respiratory and critical care medicine, 31 4, 452-62

Baughman, Robert P; Lower, Elyse E; Tami, Thomas 2010. Upper airway. 4: Sarcoidosis of the upper respiratory tract (SURT). Thorax, 65 2, 181-6

Baughman, R P; Judson, M A; Lower, E E; Highland, K; Kwon, S; Craft, N; Engel, P J 2009. Inhaled iloprost for sarcoidosis associated pulmonary hypertension. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 26 2, 110-20

de Kleijn, W P E; Elfferich, M D P; De Vries, J; Jonker, G J; Lower, E E; Baughman, R P; King, T E; Drent, M 2009. Fatigue in sarcoidosis: American versus Dutch patients. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 26 2, 92-7

Lower, Elyse E; Fleishman, Stewart; Cooper, Alyse; Zeldis, Jerome; Faleck, Herbert; Yu, Zhinuan; Manning, Donald 2009. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. Journal of pain and symptom management, 38 5, 650-62

Lower, Elyse E; Glass, Eleanor; Blau, Robbin; Harman, Stacy 2009. HER-2/neu expression in primary and metastatic breast cancer. Breast cancer research and treatment, 113 2, 301-6

Baughman, Robert P; Judson, Marc A; Teirstein, Alvin; Lower, Elyse E; Lo, Kim; Schlenker-Herceg, Rozsa; Barnathan, Elliot S 2008. Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems. American journal of clinical dermatology, 9 3, 155-61

Lower, Elyse E; Harman, Stacy; Baughman, Robert P 2008. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest, 133 5, 1189-95

Lower, Elyse E; Weiss, Kenneth L 2008. Neurosarcoidosis. Clinics in chest medicine, 29 3, 475-92, ix

Baughman, Robert P; Lower, Elyse E 2007. Six-minute walk test in managing and monitoring sarcoidosis patients. Current opinion in pulmonary medicine, 13 5, 439-44

Baughman, Robert P; Lower, Elyse E 2007. Novel therapies for sarcoidosis. Seminars in respiratory and critical care medicine, 28 1, 128-33

Baughman, Robert P; Sparkman, Brian K; Lower, Elyse E 2007. Six-minute walk test and health status assessment in sarcoidosis. Chest, 132 1, 207-13

Lower, Elyse E; Esparaz, Benjamin T; Garnett, Sally A; Wade, James L 2007. Evaluation of fulvestrant in clinical practice: use of an electronic data registry. Clinical breast cancer, 7 7, 565-9

Baughman, Robert P; Engel, Peter J; Meyer, Cris A; Barrett, Amanda B; Lower, Elyse E 2006. Pulmonary hypertension in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 23 2, 108-16

Bradley, Deborah A; Lower, Elyse E; Baughman, Robert P 2006. Diagnosis and management of spinal cord sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 23 1, 58-65

Baughman, R P; Bradley, D A; Lower, E E 2005. Infliximab in chronic ocular inflammation. International journal of clinical pharmacology and therapeutics, 43 1, 7-11

Baughman, R P; Lower, E E 2005. Fungal infections as a complication of therapy for sarcoidosis. QJM : monthly journal of the Association of Physicians, 98 6, 451-6

Baughman, Robert P; Lower, Elyse E; Bradley, Deborah A; Raymond, Lawrence A; Kaufman, Adam 2005. Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial. Chest, 128 2, 1062-47

Lower, Elyse E; Glass, Eleanor L; Bradley, Deborah A; Blau, Robbin; Heffelfinger, Sue 2005. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Breast cancer research and treatment, 90 1, 65-70

Baughman, Robert P; Lower, Elyse E 2004. Leflunomide for chronic sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 21 1, 43-8

Baughman, Robert P; Lower, Elyse E 2004. Newer therapies for cutaneous sarcoidosis: the role of thalidomide and other agents. American journal of clinical dermatology, 5 6, 385-94

Baughman, Robert P; Koehler, Allison; Bejarano, Pablo A; Lower, Elyse E; Weber, Fredrick L 2003. Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Archives of internal medicine, 163 5, 615-20

Baughman, Robert P; Lower, Elyse E; du Bois, Roland M 2003. Sarcoidosis. Lancet (London, England), 361 9363, 1111-8

Lower, Elyse E; Drosick, D Randolph; Blau, Robbin; Brennan, Lawrence; Danneman, William; Hawley, Douglas K 2003. Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. Clinical breast cancer, 4 2, 114-9

Baughman, Robert P; Iannuzzi, Michael C; Lower, Elyse E; Moller, David R; Balkissoon, Ronald C; Winget, Donna B; Judson, Marc A 2002. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 19 3, 198-204

Baughman, Robert P; Judson, Marc A; Teirstein, Alvin S; Moller, David R; Lower, Elyse E 2002. Thalidomide for chronic sarcoidosis. Chest, 122 1, 227-32

Baughman, Robert P; Lower, Elyse E 2002. Therapy for extrapulmonary sarcoidosis. Seminars in respiratory and critical care medicine, 23 6, 589-96

Baughman, Robert P; Lower, Elyse E 2002. Can persistent tumor necrosis factor release lead to refractory sarcoidosis? Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 19 3, 164-6

Bernstein, Jonathan A; Garramone, Stephen M; Lower, Elise G 2002. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 89 2, 212-4

Rohatgi, Nitin; Blau, Robbin; Lower, Elyse E 2002. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. Journal of women's health & gender-based medicine, 11 3, 291-301

Safal, Malek; Lower, Elyse E; Hasselgren, P O; Hungness, Eric S; Gazder, Paula; Aron, Bernard; Shaughnessy, Elizabeth A; Yassin, Rawia 2002. Bilateral synchronous breast cancer and HER-2/neu overexpression. Breast cancer research and treatment, 72 3, 195-201

Wobus, Manja; Rangwala, Reshma; Sheyn, Irena; Hennigan, Robert; Coila, Brigit; Lower, Elyse E; Yassin, Rawia S; Sherman, Larry S 2002. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells. Applied immunohistochemistry & molecular morphology : AIMM, 10 1, 34-9

Baughman, R P; Lower, E E 2001. Infliximab for refractory sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 18 1, 70-4

Baughman, R P; Ohmichi, M; Lower, E E 2001. Combination therapy for sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 18 2, 133-7

Lower, E E; Hawkins, H H; Baughman, R P 2001. Breast disease in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 18 3, 301-6

Baughman, R P; Winget, D B; Lower, E E 2000. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 17 1, 60-6

Hungness, E S; Safa, M; Shaughnessy, E A; Aron, B S; Gazder, P A; Hawkins, H H; Lower, E E; Seeskin, C; Yassin, R S; Hasselgren, P O 2000. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery, 128 4, 702-7

Baughman, R P; Lower, E E 1999. A clinical approach to the use of methotrexate for sarcoidosis. Thorax, 54 8, 742-6

Baughman, R P; Lower, E E; Miller, M A; Bejarano, P A; Heffelfinger, S C 1999. Overexpression of transforming growth factor-alpha and epidermal growth factor-receptor in idiopathic pulmonary fibrosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 16 1, 57-61

Lower, E E; Blau, R; Gazder, P; Stahl, D L 1999. The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer. Breast cancer research and treatment, 58 3, 205-11

Lower, E E; Blau, R; Gazder, P; Tummala, R 1999. The risk of premature menopause induced by chemotherapy for early breast cancer. Journal of women's health & gender-based medicine, 8 7, 949-54

Baughman, R P; Lower, E E 1997. Steroid-sparing alternative treatments for sarcoidosis. Clinics in chest medicine, 18 4, 853-64

Baughman, R P; Lower, E E 1997. Alternatives to corticosteroids in the treatment of sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 14 2, 121-30

Baughman, R P; Winget, D B; Bowen, E H; Lower, E E 1997. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 14 2, 154-8

Lower, E E; Broderick, J P; Brott, T G; Baughman, R P 1997. Diagnosis and management of neurological sarcoidosis. Archives of internal medicine, 157 16, 1864-8

Turner, G A; Lower, E E; Corser, B C; Gunther, K L; Baughman, R P 1997. Sleep apnea in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 14 1, 61-4

Wright, P S; Loudy, D E; Cross-Doersen, D E; Montgomery, L R; Sprinkle-Cavallo, J; Miller, J A; Distler, C M; Lower, E E; Woessner, R D 1997. Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodes. Experimental and molecular pathology, 64 1, 41-51

Heffelfinger, S C; Lower, E E; Miller, M A; Fenoglio-Preiser, C M 1996. Plasma membrane phosphotyrosine, Her2-NEU, and epidermal growth factor receptor in human breast cancer. A comparative study. American journal of clinical oncology, 19 6, 552-7

Heffelfinger, S C; Yassin, R; Miller, M A; Lower, E 1996. Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clinical cancer research : an official journal of the American Association for Cancer Research, 2 11, 1873-8

Lower, E E; Baughman, R P 1995. Prolonged use of methotrexate for sarcoidosis. Archives of internal medicine, 155 8, 846-51

Lower, E E; Miller, M A; Williams, L; Westermann, C; Heffelfinger, S 1995. Increased phosphotyrosine in breast cancer tissue is associated with a worse prognosis. Breast cancer research and treatment, 35 3, 277-82

O'Brien, G M; Baughman, R P; Broderick, J P; Arnold, L; Lower, E E 1994. Paranoid psychosis due to neurosarcoidosis. Sarcoidosis, 11 1, 34-6

Baughman, R P; Lower, E E; Flessa, H C; Tollerud, D J 1993. Thrombocytopenia in the intensive care unit. Chest, 104 4, 1243-7

Lower, E E; Franco, R S; Miller, M A; Martelo, O J 1993. Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens. Breast cancer research and treatment, 26 3, 217-24

Baughman, R P; Lower, E E 1992. Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest, 102 4, 1090-4

Lower, E E; Baughman, R P 1992. Pulmonary lymphangitic metastasis from breast cancer. Lymphocytic alveolitis is associated with favorable prognosis. Chest, 102 4, 1113-7

Lower, E E; Franco, R S; Martelo, O J 1992. Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias. The American journal of the medical sciences, 303 6, 387-91

Pavelic, Z P; Pavelic, L; Lower, E E; Gapany, M; Gapany, S; Barker, E A; Preisler, H D 1992. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma. Cancer research, 52 9, 2597-602

Baughman, R P; Lower, E E 1991. An inhibitor of tumor necrosis factor found in pleural effusions. The Journal of laboratory and clinical medicine, 118 4, 326-31

Baughman, R P; Shipley, R T; Loudon, R G; Lower, E E 1991. Crackles in interstitial lung disease. Comparison of sarcoidosis and fibrosing alveolitis. Chest, 100 1, 96-101

Baughman, R P; Lower, E E 1990. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. The American review of respiratory disease, 142 6 Pt 1, 1268-71

Baughman, R P; Strohofer, S A; Buchsbaum, J; Lower, E E 1990. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. The Journal of laboratory and clinical medicine, 115 1, 36-42

Lower, E E; Baughman, R P 1990. The use of low dose methotrexate in refractory sarcoidosis. The American journal of the medical sciences, 299 3, 153-7

Lower, E E; Baughman, R P 1990. The effect of cancer and chemotherapy on monocyte function. Journal of clinical & laboratory immunology, 31 3, 121-5

Baughman, R P; Doers, J; Lower, E E; Buchsbaum, J 1989. Isolation of functionally active pleural macrophages. Journal of clinical & laboratory immunology, 30 3, 147-51

Baughman, R P; Lower, E E; Pierson, G; Strohofer, S 1988. Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers. The Journal of laboratory and clinical medicine, 111 4, 399-404

Lower, E E; Smith, J T; Martelo, O J; Baughman, R P 1988. The anemia of sarcoidosis. Sarcoidosis, 5 1, 51-5

Lower, E E; Strohofer, S; Baughman, R P 1988. Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide. The American journal of the medical sciences, 295 3, 193-7

Pelstring, R J; Kim, C K; Lower, E E; Swerdlow, S H 1988. Marrow granulomas in coal workers' pneumoconiosis. A histologic study with elemental analysis. American journal of clinical pathology, 89 4, 553-6

Sturdivant M.;Baughman R.;Lower E. 12-18-2019. Presence of onconeural antibodies in sarcoidosis patients with parasarcoidosis syndrome Sarcoidosis Vasculitis and Diffuse Lung Diseases, 36 4, 254-260

Baughman R.;Lower E. 12-01-2009. Sarcoidosis A Clinician's Pearls and Myths in Rheumatology, , 409-420

Baughman R.;Lower E.;Engel P. 12-01-2009. Sarcoidosis Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide, , 213-242

Baughman R.;Lower E.;Drent M. 12-01-2008. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: Who, what, and how to use them Sarcoidosis Vasculitis and Diffuse Lung Diseases, 25 2, 76-89

Rossman M.D.;Thompson B.;Frederick M.;Iannuzzi M.C.;Rybicki B.A.;Pandey J.P.;Newman L.S.;Rose C.;Magira E.;Monos D.;Weinberger S.E.;Finn P.;Garpestad E.;Moran A.;Yeager H.;Rabin D.L.;Stein S.;Major M.;Maliarik M.;Popovich J.;Moller D.R.;Johns C.J.;Rand C.;Steimel J.;Judson M.A.;D'Alessandro S.;Heister N.;Johnson T.;Lackland D.T.;Sahn S.;Strange C.;Teirstein A.S.;DePalo L.;Brown S.;Lesser M.;Padilla M.L.;Marshall M.;Barnard J.;Baughman R.P.;Lower E.E.;Winget D.B.;McLennan G.;Hunninghake G.;Dayton C.;Powers L.;Bresnitz E.A.;Daniele R.;Regovich J.;Sexauer W.;Musson R.;Deshler J.;Sorlie P.;Wu M.;Cherniack R.;Knatterud G.L.;Terrin M.L.;Thompson B.W.;Brown K.;Frederick M.;LoPresti F.;Wilkins P.;Canner M.;Dotson J.;Lindenfelser S.;Cosentino M. 12-01-2008. HLA and environmental interactions in sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases, 25 2, 125-132

Jones S.E.;Erban J.;Overmoyer B.;Budd G.T.;Hutchins L.;Lower E.;Laufman L.;Sundaram S.;Urba W.J.;Pritchard K.I.;Mennel R.;Richards D.;Olsen S.;Meyers M.L.;Ravdin P.M. 12-01-2005. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer Journal of Clinical Oncology, 23 24, 5542-5551

Gradishar W.J.;Meza L.A.;Amin B.;Samid D.;Hill T.;Chen Y.M.;Lower E.E.;Marcom P.K. 12-01-2004. Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multi Journal of Clinical Oncology, 22 12, 2321-2327

Gradishar W.J.;Meza L.A.;Amin B.;Samid D.;Hill T.;Chen Y.M.;Lower E.E.;Marcom P.K.;Iqbal S. 12-01-2004. Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multi Women's Oncology Review, 4 4, 283-285

Baughman R.;Lower E. 12-01-2002. Therapy for extrapulmonary sarcoidosis Seminars in Respiratory and Critical Care Medicine, 23 6, 589-596

Marcott C.;Story G.;Lower E.;Yassin R.;Johnson B.;Dukor R. 12-01-2002. Infrared spectroscopic imaging looking for diagnostic chemical markers Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings, 2 , 1145-1146

Baughman R.;Lower E. 12-01-1998. Alternatives to corticosteroids in the treatment of sarcoidosis Pneumologie, 52 1, 33

Baughman R.;Winget D.;Bowen E.;Lower E. 12-01-1998. Predicting respiratory failure in sarcoidosis patients Pneumologie, 52 1, 33

Turner G.;Lower E.;Corser B.;Gunther K.;Baughman R. 12-01-1997. Sleep apnoe in sarcoidosis Pneumologie, 51 9, 924

Baughman R.; Lower E.; Winget D. 12-01-1992. The long term use of methotrexate in patients with chronic symptomatic sarcoidosis Sarcoidosis, 9 SUPPL. 1, 465-466

Lower E.;Baughman R.;Winget D. 12-01-1992. The long term use of methotrexate in patients with chronic symptomatic sarcoidosis Sarcoidosis, 9 SUPPL. 1, 465-466

Baughman R.;Costabel U.;Lower E. 11-01-2012. Drug therapy for interstitial lung disease Diffuse Lung Disease: A Practical Approach: Second Edition, 9781441997715 , 101-120

Baughman R.;Engel P.;Taylor L.;Lower E. 11-01-2010. Survival in sarcoidosis-associated pulmonary hypertension: The importance of hemodynamic evaluation Chest, 138 5, 1078-1085

Lower E.;Baughman R.;Kaufman A. 10-04-2012. Rituximab for refractory granulomatous eye disease Clinical Ophthalmology, 6 1, 1613-1618

Zheng G.;Tian X.;Weinberger S.E.;Finn P.;Garpestad E.;Moran A.;Yeager H.;Rabin D.L.;Stein S.;Iannuzzi M.C.;Rybicki B.A.;Major M.;Maliarik M.;Popovich J.;Moller D.R.;Johns C.J.;Rand C.;Steimel J.;Judson M.A.;Alessandro S.D.;Heister N.;Johnson T.;Lackland D.T.;Pandey J.;Sahn S.;Strange C.;Teirstein A.S.;DePalo L.;Brown S.;Lesser M.;Padilla M.L.;Marshall M.;Newman L.S.;Rose C.;Barnard J.;Baughman R.P.;Lower E.E.;Winget D.B.;McLennan G.;Hunninghake G.;Dayton C.;Powers L.;Rossman M.D.;Bresnitz E.A.;Daniele R.;Regovich J.;Sexauer W.;Musson R.;Deshler J.;Sorlie P.;Wu M.;Cherniak R.;Newman L.;Knatterud G.L.;Terrin M.L.;Thompson B.W.;Brown K.;Frederick M.;LoPresti F.;Wilkins P.;Canner M.;Dotson J.;Lindenfelser S.;Cosentino M.;Maliarik M.;Baughman R.;Rossman M.;Monos D.;Lee C.W.;Moller D.;Pandey J.;Almenoff P.;Brett I.;Brown S.;Lesser M.;Newman L.;Kotzin B.;McLennan G.;Hunninghake G.;Finn P.;Jaffe R.D.;Cherniack R.;Baughman R.P.;Deshler J.;Judson M.A.;Knatterud G.L.;McLennan G.;Moller D.R.;Musson R.A.;Newman L.S.;Rossman M.D.;Teirstein A.S.;Terrin M.L.;Martin W.;Ashikaga T.;Coultas D.B.;Davis G.S.;Gifford F. 09-30-2006. Robust trend tests for genetic association using matched case-control design Statistics in Medicine, 25 18, 3160-3173

Jonth A.C.;Silveira L.;Fingerlin T.E.;Sato H.;Luby J.C.;Welsh K.I.;Rose C.S.;Newman L.S.;Du Bois R.M.;Maier L.A.;Weinberger S.E.;Finn P.;Garpestad E.;Moran A.;Yeager H.;Rabin D.L.;Stein S.;Iannuzzi M.C.;Rybicki B.A.;Major M.;Maliarik M.;Popovich J.;Moller D.R.;Johns C.J.;Rand C.;Steimel J.;Judson M.A.;D'Alessandro S.;Heister N.;Johnson T.;Lackland D.T.;Pandey J.;Sahn S.;Strange C.;Teirstein A.S.;DePalo L.;Brown S.;Lesser M.;Padilla M.L.;Marshall M.;Rose C.;Barnard J.;Martyny J.;McCammon C.;Baughman R.P.;Lower E.E.;Winget D.B.;McLennan G.;Hunninghake G.;Dayton C.;Powers L.;Rossman M.D.;Bresnitz E.A.;Daniele R.;Regovich J.;Sexauer W.;Musson R.;Deshler J.;Sorlie P.;Wu M.;Cherniack R.;Newman L.;Knatterud G.L.;Terrin M.L.;Thompson B.W.;Brown K.;Frederick M.;LoPresti F.;Wilkins P.;Canner M.;Dotson J.;Lindenfelser S.;Cosentino M. 09-15-2007. TGF-?1 variants in chronic beryllium disease and sarcoidosis Journal of Immunology, 179 6, 4255-4262

Baughman R.;Lower E. 09-01-2017. Measuring sarcoidosis around the world: Using the same ruler Revista Portuguesa de Pneumologia (English Edition), 23 5, 247-248

De Kleijn W.;De Vries J.;Lower E.;Elfferich M.;Baughman R.;Drent M. 09-01-2009. Fatigue in sarcoidosis: A systematic review Current Opinion in Pulmonary Medicine, 15 5, 499-506

Baughman R.;Lower E. 08-17-2017. Sarcoidosis-associated pulmonary hypertension: Diagnosis and treatment Pulmonary Hypertension and Interstitial Lung Disease, , 129-143

Lower E.;Khan S.;Kennedy D.;Baughman R. 08-02-2017. Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and Breast Cancer: Targets and Therapy, 9 , 515-520

Baughman R.;Lower E. 07-07-2009. Diagnosis of Pneumonia in Immunocompromised Patient Pulmonary Infection in the Immunocompromised Patient: Strategies for Management, , 53-93

Drent M.;Lower E.;De Vries J. 07-01-2012. Sarcoidosis-associated fatigue European Respiratory Journal, 40 1, 255-263

Baughman R.;Lower E. 06-01-2011. Who dies from sarcoidosis and why? American Journal of Respiratory and Critical Care Medicine, 183 11, 1446-1447

Sweiss N.;Lower E.;Korsten P.;Niewold T.;Favus M.;Baughman R. 06-01-2011. Bone health issues in sarcoidosis Current Rheumatology Reports, 13 3, 265-272

Baughman R.;Lower E. 05-23-2014. Goldilocks, vitamin D and sarcoidosis Arthritis Research and Therapy, 16 3,

Sweiss N.J.;Lower E.E.;Mirsaeidi M.;Dudek S.;Garcia J.G.N.;Perkins D.;Finn P.W.;Baughman R.P. 05-01-2014. Rituximab in the treatment of refractory pulmonary sarcoidosis European Respiratory Journal, 43 5, 1525-1528

Baughman R.;Lower E. 05-01-2004. New therapies for sarcoidosis Clinical Pulmonary Medicine, 11 3, 154-160

Baughman R.;Lower E. 05-01-2003. The variability of sarcoidosis: Can we predict it? Chest, 123 5, 1329-1332

Baughman R.;Lower E. 04-29-1998. Treatment of sarcoidosis with corticosteroids: Who is going to relapse and why? Sarcoidosis Vasculitis and Diffuse Lung Disease, 15 1, 19-20

Baughman R.;Lower E. 04-19-2016. Immunosuppressive and cytotoxic drug therapy for diffuse ILD Interstitial Pulmonary and Bronchiolar Disorders, , 119-161

Gvozdenovic B.;Mihailovic-Vucinic V.;Vukovic M.;Lower E.;Baughman R.;Dudvarski-Ilic A.;Zugic V.;Popevic S.;Videnovic-Ivanov J.;Filipovic S.;Stjepanovic M.;Omcikus M. 04-01-2013. Effect of obesity on patient-reported outcomes in sarcoidosis International Journal of Tuberculosis and Lung Disease, 17 4, 559-564

Baughman R.P.;Tillinger M.;Qin Y.;Sweiss N.;Lower E.E. 03-21-2019. A composite score to assess treatment response in pulmonary sarcoidosis: The sarcoidosis treatment S Sarcoidosis Vasculitis and Diffuse Lung Diseases, 36 1, 86-88

Baughman R.;Lower E. 02-15-2012. Sarcoidosis mortality American Journal of Respiratory and Critical Care Medicine, 185 4, 462

Baughman R.;Judson M.;Ingledue R.;Craft N.;Lower E. 02-01-2012. Efficacy and safety of apremilast in chronic cutaneous sarcoidosis Archives of Dermatology, 148 2, 262-264

Kittaneh M.;Badve S.;Caldera H.;Coleman R.;Goetz M.P.;Mahtani R.;Mamounas E.;Kalinsky K.;Lower E.;Pegram M.;Press M.F.;Rugo H.S.;Schwartzberg L.;Traina T.;Vogel C. 01-01-2020. Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Clinical Breast Cancer, ,

Mahtani R.;Holmes F.A.;Badve S.;Caldera H.;Coleman R.;Mamounas E.;Kalinsky K.;Kittaneh M.;Lower E.;Pegram M.;Press M.F.;Rugo H.S.;Schwartzberg L.;Vogel C. 01-01-2020. A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Clinical Breast Cancer, ,

Ruiz-Torres S.;Benight N.;Karns R.;Lower E.;Guan J.;Waltz S. 01-01-2017. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canoni Oncotarget, 8 35, 58918-58933

Zhou Y.;Lower E.E.;Li H.;Baughman R.P. 01-01-2016. Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel Respiratory Medicine Case Reports, 17 , 5-7

Carbone R.;Penna D.;Baughman R.;Lower E. 01-01-2014. Accuracy of serial PET-CT imaging in systemic sarcoidosis Journal of Clinical Imaging Science, 4 1,

Judson M.A.;Costabel U.;Drent M.;Wells A.;Maier L.;Koth L.;Shigemitsu H.;Culver D.A.;Gelfand J.;Valeyre D.;Sweiss N.;Crouser E.;Morgenthau A.S.;Lower E.E.;Azuma A.;Ishihara M.;Morimoto S.;Yamaguchi T.;Shijubo N.;Grutters J.C.;Rosenbach M.;Li H.P.;Rottoli P.;Inoue Y.;Prasse A.;Baughman R.P.;Baughman R.;Soskel N.;Wells A.;Crouser E.;Koth L.;Drent M.;Rittoli P.;Culver D.;Rossman M.;Costabel U.;Maier L.;Valeyre D.;Shigemitsu H.;Sweiss N.;Israel-Biet D.;Neto M.R.;Gupta D.;Carmona E.;Patterson K.;Matragrano A.P.;Rosenbach M.;Westney G.;Sahoo D.;Lower E.;Gelfand J.;Stern B.;Tavee J.;Hoitsma E.;Nozaki K.;Aubart F.C.;Hamzeh N.;Vedantham V.;Chapelon C.;Bernie D.;Bandyopadhyay D.;Gross A.;Yee A. 01-01-2014. The WASOG sarcoidosis organ assessment instrument: An update of a previous clinical tool Sarcoidosis Vasculitis and Diffuse Lung Diseases, 31 1, 19-27

Baughman R.;Lower E.;Gibson K. 01-01-2012. Pulmonary manifestations of sarcoidosis Presse Medicale, 41 6 PART 2,

Baughman R.;Lower E.;Tami T. 01-01-2010. Upper airway.4: Sarcoidosis of the upper respiratory tract (SURT) Thorax, 65 2, 181-186

De Vries J.;Lower E.;Drent M. 01-01-2010. Quality of life in sarcoidosis: Assessment and management Seminars in Respiratory and Critical Care Medicine, 31 4, 485-493

Lower E.;Harman S.;Baughman R. 01-01-2008. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis- Chest, 133 5, 1189-1195

Lower E.;Esparaz B.;Garnett S.;Wade J. 01-01-2007. Evaluation of fulvestrant in clinical practice: Use of an electronic data registry Clinical Breast Cancer, 7 7, 565-569

Baughman R.;Lower E. 01-01-2005. Future direction of therapy for sarcoidosis Sarcoidosis, , 785-800

Lower E. 01-01-2005. Rare forms of sarcoidosis Sarcoidosis, , 651-670

Lower E.E.;Drosick D.R.;Blau R.;Brennan L.;Danneman W.;Hawley D.K. 01-01-2003. Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival Clinical Breast Cancer, 4 2, 114-119

Baughman R.;Lower E. 01-01-2001. Erratum: Infliximab for refractory sarcoidosis (Sarcoidosis Vasculitis and Diffuse Lung Disease (Mar Sarcoidosis Vasculitis and Diffuse Lung Diseases, 18 3, 310

Lower E.E.;Blau R.;Bismayer J.;Brennan L.;Broun R.;Danneman W.;Drosick D.R.;Hawley D.K. 01-01-2001. Increased brain metastasis detected in metastatic breast cancer patients receiving herceptin Breast Cancer Research and Treatment, 69 3, 271

Baughman R.;Bresnitz E.;Iannuzzi M.;Johns C.;Knatterud G.L.;McLennan G.;Moller D.;Musson R.;Newman L.S.;Rabin D.;Rossman M.D.;Teirstein A.;Terrin M.L.;Thompson B.W.;Weinberger S.;Finn P.;Moran A.;Weiss S.T.;Yeager H. J.;Rabin D.L.;Stein S.;Rybicki B.;Major M.;Maliarik M.;Popovich J. J.;Moller D.R.;Johns C.J.;Rand C.;Steimel J.;Judson M.A.;Johnson T.;Lackland D.T.;Pandey J.;Sahn S.;Strange C.;DePalo L.;Almenoff P.;Brown S.;Lesser M.;Marshall M.;Newman L.S.;Rose C.;Barnard J.;Lower E.E.;Bowen E.H.;Winget D.B.;McLennan G.;Hunningshake G.;Dayton C.;Strutzman J.;Rossman M.D.;Dow D.;Sexauer W. 01-01-1999. Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS) Journal of Clinical Epidemiology, 52 12, 1173-1186

Baughman R.;Lower E. 01-01-1999. New treatment for sarcoidosis: Where's the proof? European Respiratory Journal, 14 5, 1000-1001

Baughman R.; Lower E. 01-01-1996. Immunosuppressant therapy for idiopathic pulmonary fibrosis Clinical Immunotherapeutics, 6 6, 431-442

Baughman R.;Lower E. 01-01-1996. Immunosuppressant therapy for idiopathic pulmonary fibrosis Clinical Immunotherapeutics, 6 6, 431-442

Baughman, R P; Gunther, K L; Buchsbaum, J A; Lower, E E . Prevalence of digital clubbing in bronchogenic carcinoma by a new digital index. Clinical and experimental rheumatology, 16 1, 21-6

Baughman, R P; Lower, E E . Measuring sarcoidosis around the world: Using the same ruler. Revista portuguesa de pneumologia, 23 5, 247-248

Baughman, Robert P; Lower, Elyse E . Evidence-based therapy for cutaneous sarcoidosis. Clinics in dermatology, 25 3, 334-40

Heffelfinger, S C; Yassin, R; Miller, M A; Lower, E E . Cyclin D1, retinoblastoma, p53, and Her2/neu protein expression in preinvasive breast pathologies: correlation with vascularity. Pathobiology : journal of immunopathology, molecular and cellular biology, 68 3, 129-36

Lower, Elyse E; Khan, Shagufta . Biomarker discordance: why it occurs and why it is important. Cancer biomarkers : section A of Disease markers, 12 6, 219-30